Old TB vaccine may stop diabetes before it starts
NCT ID NCT05591339
First seen Feb 18, 2026 · Last updated May 16, 2026 · Updated 12 times
Summary
This study tests whether the BCG vaccine (used for tuberculosis) can prevent type 2 diabetes in adults with pre-diabetes in Guinea-Bissau. Researchers believe the vaccine may reduce inflammation and insulin resistance. 200 participants will receive BCG and be monitored for diabetes development over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bandim Health Project
Bissau, 1004, Guinea-Bissau
Conditions
Explore the condition pages connected to this study.